TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34511132 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 34511132 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 34511898 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34511898 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 34511974 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34511974 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34511974 — Safety Biomarker (SAF): IL-6 and IL-10
Study 34511975 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study 34512058 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34513679 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 34514286 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34514436 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34514436 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34515148 — Predictive Biomarker (PRD): TCF7L2 mRNA
Genes: TCF7L2; TCF4
Study 34515215 — Predictive Biomarker (PRD): CDH6 mRNA
Genes: CDH6
Study 34516656 — Predictive Biomarker (PRD): PRKRA mRNA
Genes: PRKRA; PACT; RAX; HSD-14; HSD14
Study 34516954 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34516954 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34516956 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 34518090 — Surrogate Endpoint (SUR): Serum uric acid
Study 34518162 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34518162 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34518555 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34518555 — Safety Biomarker (SAF): BDNF
Study 34519331 — Surrogate Endpoint (SUR): Blood pressure
Study 34519823 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study 34519823 — Predictive Biomarker (PRD): COL1A2 mRNA
Genes: COL1A2
Study 34519839 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 34519964 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34519964 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34521364 — Surrogate Endpoint (SUR): Blood pressure
Study 34521667 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34521694 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 34521694 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34521729 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34522028 — Predictive Biomarker (PRD): SMOX mRNA
Genes: SMOX; C20orf16; SMO; UNQ3039/PRO9854
Study 34522028 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study 34522028 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study 34522028 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 34522093 — Predictive Biomarker (PRD): LRIT1 mRNA
Genes: LRIT1; LRRC21; PAL
Study 34523725 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 34523741 — Surrogate Endpoint (SUR): Blood pressure
Study 34524220 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34524220 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34524220 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 34525286 — Predictive Biomarker (PRD): IFNAR1 mRNA
Genes: IFNAR1; IFNAR
Study 34526044 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34526058 — Predictive Biomarker (PRD): RNPEP mRNA
Genes: RNPEP; APB
Study 34526343 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 34527321 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34527321 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34527722 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 34528763 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34528763 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 34528763 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 34528763 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34528763 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34528763 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 34528763 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study 34529005 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 34529762 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34530387 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 34530733 — Surrogate Endpoint (SUR): Blood pressure
Study 34530744 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34530760 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34530760 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34530760 — Predictive Biomarker (PRD): IKZF1 mRNA
Genes: IKZF1; IK1; IKAROS; LYF1; ZNFN1A1
Study 34530760 — Predictive Biomarker (PRD): IKZF3 mRNA
Genes: IKZF3; ZNFN1A3
Study 34531249 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 34531249 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34531249 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 34531250 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 34531264 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34531537 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 34531588 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study 34532768 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 34534134 — Surrogate Endpoint (SUR): Blood pressure
Study 34534180 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 34534188 — Surrogate Endpoint (SUR): Blood pressure
Study 34534430 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34536405 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 34538257 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34538263 — Predictive Biomarker (PRD): DIP2C mRNA
Genes: DIP2C; KIAA0934
Study 34538263 — Predictive Biomarker (PRD): APOH mRNA
Genes: APOH; B2G1
Study 34538263 — Predictive Biomarker (PRD): PRKCA mRNA
Genes: PRKCA; PKCA; PRKACA
Study 34539750 — Predictive Biomarker (PRD): CXCL16 mRNA
Genes: CXCL16; SCYB16; SRPSOX; UNQ2759/PRO6714
Study 34540013 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34540651 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study 34540651 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 34540651 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study 34540651 — Predictive Biomarker (PRD): L1CAM mRNA
Genes: L1CAM; CAML1; MIC5
Study 34540651 — Predictive Biomarker (PRD): Microsatellite instability
Study 34540696 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 34542729 — Surrogate Endpoint (SUR): Blood pressure
Study 34542871 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study 34542871 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 34542871 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34543230 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34543477 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34543753 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34544430 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34547326 — Predictive Biomarker (PRD): S1PR2 mRNA
Genes: S1PR2; EDG5
Study 34548198 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 34548240 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34548595 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 34550085 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34550085 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34550085 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34550085 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 34550633 — Predictive Biomarker (PRD): MAML2 mRNA
Genes: MAML2; KIAA1819
Study 34550633 — Predictive Biomarker (PRD): TOP2A mRNA
Genes: TOP2A; TOP2
Study 34551507 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 34551507 — Safety Biomarker (SAF): Interleukin 1
Study 34551738 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 34552864 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study 34554571 — Predictive Biomarker (PRD): SULT1A3 mRNA
Genes: SULT1A3; STM
Study 34554584 — Predictive Biomarker (PRD): TK1 mRNA
Genes: TK1
Study 34554584 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 34556565 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study 34556649 — Predictive Biomarker (PRD): NECAB3 mRNA
Genes: NECAB3; APBA2BP; NIP1; SYTIP2; XB51
Study 34556649 — Surrogate Endpoint (SUR): Blood pressure
Study 34557558 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34558001 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 34558059 — Predictive Biomarker (PRD): REG3A mRNA
Genes: REG3A; HIP; PAP; PAP1
Study 34558059 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34558059 — Predictive Biomarker (PRD): IL17C mRNA
Genes: IL17C; UNQ561/PRO1122
Study 34559360 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study 34559851 — Surrogate Endpoint (SUR): Blood pressure
Study 34560047 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 34560789 — Surrogate Endpoint (SUR): Blood pressure
Study 34561812 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34562096 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34562096 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34562103 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study 34562193 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34562313 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34563945 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 34564048 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34564048 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 34564048 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 34564780 — Surrogate Endpoint (SUR): Blood pressure
Study 34564955 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study 34567118 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34568006 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34568006 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34568058 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34568375 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 34569467 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34570185 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 34570185 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 34570352 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 34570352 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34574679 — Surrogate Endpoint (SUR): Blood pressure
Study 34575252 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 34579646 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 34579767 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34580115 — Monitoring Biomarker (MOI): Circulating tumor HPV DNA
Study 34580115 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34580668 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34580668 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34580673 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 34581517 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34581550 — Surrogate Endpoint (SUR): Blood pressure
Study 34581757 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 34581757 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 34581778 — Predictive Biomarker (PRD): CALR mRNA
Genes: CALR; CRTC
Study 34582307 — Surrogate Endpoint (SUR): Blood pressure
Study 34582355 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAC mRNA
Genes: STAC; STAC1
Study 34583690 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34585083 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34585271 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34585271 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 34585271 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study 34585621 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34586748 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34587198 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34587198 — Surrogate Endpoint (SUR): Blood pressure
Study 34588193 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34588193 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34589194 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study 34589419 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 34589918 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 34589965 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study 34589984 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34590048 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34590052 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34590303 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34592057 — Pharmacodynamic Biomarker (PDY): Beta-secretase 1
Genes: BACE1; BACE; KIAA1149
Study 34592057 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study 34592319 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 34592755 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34593173 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 34593270 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 34593600 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study 34594036 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34595805 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34595805 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34596097 — Surrogate Endpoint (SUR): Bone mineral density
Study 34597119 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 34597119 — Surrogate Endpoint (SUR): Serum testosterone
Study 34598945 — Predictive Biomarker (PRD): LILRB2 mRNA
Genes: LILRB2; ILT4; LIR2; MIR10
Study 34598945 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 34599020 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 34599020 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34599023 — Predictive Biomarker (PRD): TYRO3 mRNA
Genes: TYRO3; BYK; DTK; RSE; SKY; TIF
Study 34599023 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 34599023 — Predictive Biomarker (PRD): MERTK mRNA
Genes: MERTK; MER
Study 34599023 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34599023 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34599023 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34599023 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34599228 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study 34599228 — Predictive Biomarker (PRD): TMEM132C mRNA
Genes: TMEM132C
Study 34599228 — Predictive Biomarker (PRD): ZNF469 mRNA
Genes: ZNF469; KIAA1858
Study 34600119 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34601646 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34601646 — Predictive Biomarker (PRD): PPP6R3 mRNA
Genes: PPP6R3; C11orf23; KIAA1558; PP6R3; SAPL; SAPS3
Study 34601959 — Surrogate Endpoint (SUR): Blood pressure
Study 34601970 — Surrogate Endpoint (SUR): Serum potassium
Study 34602290 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 34602290 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 34602290 — Predictive Biomarker (PRD): RAD51C mRNA
Genes: RAD51C; RAD51L2
Study 34604072 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34605220 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 34605220 — Safety Biomarker (SAF): Reactive oxygen species
Study 34605552 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34606062 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6
Study 34606062 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study 34606062 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 34606062 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 34606104 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 34606104 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34607348 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34607575 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34607609 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34607609 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34607899 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34607899 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34608577 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 34609195 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34610114 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 34610114 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 34610808 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34610874 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 34611424 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34612019 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 34612058 — Predictive Biomarker (PRD): miR-101-3p
Study 34614208 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34614208 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34615429 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34615705 — Predictive Biomarker (PRD): PNKD mRNA
Genes: PNKD; KIAA1184; MR1; TAHCCP2; FKSG19; UNQ2491/PRO5778
Study 34615723 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 34615723 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 34615723 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34615725 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34617912 — Surrogate Endpoint (SUR): Blood pressure
Study 34618197 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34618197 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study 34618321 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34618347 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34618347 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34618930 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 34618930 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 34618930 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 34618930 — Surrogate Endpoint (SUR): Forced vital capacity